Guth A - Search Results

1

Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity.

Guth A, Monk E, Agarwal R, Bergman BC, Zemski-Berry KA, Minic A, Jordan K, Schlaepfer IR. Guth A, et al. Int J Mol Sci. 2020 Dec 18;21(24):9660. doi: 10.3390/ijms21249660. Int J Mol Sci. 2020. PMID: 33352903 Free PMC article.

2

Changes in regulatory T cells in dogs with cancer and associations with tumor type.

O'Neill K, Guth A, Biller B, Elmslie R, Dow S. O'Neill K, et al. Among authors: guth a. J Vet Intern Med. 2009 Jul-Aug;23(4):875-81. doi: 10.1111/j.1939-1676.2009.0333.x. Epub 2009 Jun 1. J Vet Intern Med. 2009. PMID: 19496904 Free article.

3

Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma.

Biller BJ, Guth A, Burton JH, Dow SW. Biller BJ, et al. Among authors: guth a. J Vet Intern Med. 2010 Sep-Oct;24(5):1118-23. doi: 10.1111/j.1939-1676.2010.0557.x. Epub 2010 Jul 28. J Vet Intern Med. 2010. PMID: 20666983 Free PMC article.

4

Immune regulation of canine tumour and macrophage PD-L1 expression.

Hartley G, Faulhaber E, Caldwell A, Coy J, Kurihara J, Guth A, Regan D, Dow S. Hartley G, et al. Among authors: guth a. Vet Comp Oncol. 2017 Jun;15(2):534-549. doi: 10.1111/vco.12197. Epub 2016 Feb 4. Vet Comp Oncol. 2017. PMID: 26842912

5

PD-1 expression by canine T cells and functional effects of PD-1 blockade.

Coy J, Caldwell A, Chow L, Guth A, Dow S. Coy J, et al. Among authors: guth a. Vet Comp Oncol. 2017 Dec;15(4):1487-1502. doi: 10.1111/vco.12294. Epub 2017 Jan 25. Vet Comp Oncol. 2017. PMID: 28120417

6

Cancer stem cell populations in lymphoma in dogs and impact of cytotoxic chemotherapy.

Hartley G, Elmslie R, Murphy B, Hopkins L, Guth A, Dow S. Hartley G, et al. Among authors: guth a. Vet Comp Oncol. 2019 Mar;17(1):69-79. doi: 10.1111/vco.12447. Epub 2018 Oct 21. Vet Comp Oncol. 2019. PMID: 30238600 Free PMC article.

7

The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.

Regan DP, Coy JW, Chahal KK, Chow L, Kurihara JN, Guth AM, Kufareva I, Dow SW. Regan DP, et al. J Immunol. 2019 May 15;202(10):3087-3102. doi: 10.4049/jimmunol.1800619. Epub 2019 Apr 10. J Immunol. 2019. PMID: 30971441 Free PMC article.

8

A novel cancer immunotherapy utilizing autologous tumour tissue.

Park H, Gladstone M, Shanley C, Goodrich R, Guth A. Park H, et al. Among authors: guth a. Vox Sang. 2020 Aug;115(6):525-535. doi: 10.1111/vox.12935. Epub 2020 May 6. Vox Sang. 2020. PMID: 32378223 Free PMC article.

9

Pilot Acute Safety Evaluation of Innocell™ Cancer Immunotherapy in Canine Subjects.

Goodrich RP, Weston J, Hartson L, Griffin L, Guth A. Goodrich RP, et al. Among authors: guth a. J Immunol Res. 2020 Oct 8;2020:7142375. doi: 10.1155/2020/7142375. eCollection 2020. J Immunol Res. 2020. PMID: 33102607 Free PMC article.

10

Type I interferons inhibit the generation of tumor-associated macrophages.

U'Ren L, Guth A, Kamstock D, Dow S. U'Ren L, et al. Among authors: guth a. Cancer Immunol Immunother. 2010 Apr;59(4):587-98. doi: 10.1007/s00262-009-0776-6. Epub 2009 Oct 14. Cancer Immunol Immunother. 2010. PMID: 19826812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters